Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

  • T. T. Chang
  • , Y. C. Chao
  • , V. V. Gorbakov
  • , K. H. Han
  • , R. G. Gish
  • , R. De Man
  • , H. Cheinquer
  • , F. Bessone
  • , H. Brett-Smith
  • , R. Tamez

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)784-789
Number of pages6
JournalJournal of Viral Hepatitis
Volume16
Issue number11
DOIs
StatePublished - Nov 2009
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology
  • Infectious Diseases
  • Virology

Keywords

  • Entecavir
  • HBV
  • Hepatitis B
  • Lamivudine

Cite this